- Home
- Advocacy
- Latest News and Practice Data
- New guidance on DOAC testing
The Association for Diagnostics and Laboratory Medicine (ADLM) has issued updated guidance on coagulation testing for patients using direct oral anticoagulants (DOACs).
Coagulation testing remains a critical tool for diagnosing bleeding and clotting disorders, guiding treatment decisions, and monitoring patient outcomes. With the growing range of anticoagulation therapies, DOACs have emerged as a convenient alternative to traditional blood thinners, offering effective management without the need for routine monitoring.
These new recommendations aim to help clinicians ensure that patients taking DOACs receive accurate test results, appropriate diagnoses, and optimal care.
Learn more: Read the updated guidance.